Discover trends, market shifts, and competitive outlooks for the pharmacovigilance industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

What Is the Estimated Market Size of the Pharmacovigilance Market In 2029?

In the past few years, there has been a significant expansion in the pharmacovigilance market size. The market is projected to escalate from a worth of $8.58 billion in 2024 to a staggering $9.73 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 13.5%. This growth during the historical period is primarily due to the heightened occurrence of adverse drug reactions (ADRs), increased research and development (R&D) operations, surging rate of drug development, an intensified focus on personalized medicine, and a climbing prevalence of chronic ailments.

In the coming years, the pharmacovigilance market is predicted to experience substantial expansion, reaching an estimated worth of $15.83 billion by 2029, at a compound annual growth rate (CAGR) of 12.9%. Factors contributing to this growth phase within the forecast period include an escalation in healthcare spending, enhanced government backing, and an aging demographic. Ascending trends projected within this span involve heightened investments, the integration of artificial intelligence, the adoption of inventive platforms and innovative cloud-based systems, and strategic partnering through mergers and acquisitions.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=5928&type=smp

Which Factors and External Forces Are Driving Demand in the Pharmacovigilance Market?

The pharmacovigilance market is propelled forward by heightened research and development ventures. The production of new and inventive medications with enhanced safety profiles becomes possible through substantial investments in R&D by pharmaceutical firms. In-depth preclinical and clinical examinations during the developmental stages of drugs also play a part in recognizing potential safety issues early on, enabling the application of effective risk management practices. In addition to this, R&D initiatives further the progression of technologies meant for monitoring adverse events, analyzing data, and detecting signals. This leads to the early identification of adverse reactions to drugs in the post-marketing period. A case in point is when Llywodraeth Cymru Welsh Government, a UK-based government entity, reported in February 2024 that in 2022, Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD), comprising 1.9% of the UK’s total expenditure in this sector. Consequently, the ascent in research and development endeavors has played a significant role in boosting the pharmacovigilance market.

Which Segments in the Pharmacovigilance Offer the Most Growth?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=5928&type=smp

What Are the Fastest-Growing Geographies in the #Which Factors and External Forces Are Driving Demand in the Pharmacovigilance Market?# Market?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which Cutting-Edge Market Trends Are Expected to Drive thePharmacovigilance Market’s Growth?

Firms operating in the pharmacovigilance industry are leveraging the power of artificial intelligence (AI) to boost efficiency. By embracing AI, such companies can enhance the precision and efficacy of their pharmacovigilance efforts which in turn can lead to improved patient outcomes. AI makes it possible for pharmaceutical firms to expedite their processes, refine their data management endeavors, and quicken drug discovery, all the while cutting costs and raising safety. For instance, the Indian Government introduced the Adverse Drug Reaction Monitoring System (ADRMS) software in August 2024. This pharmacovigilance tool was unveiled by the Minister of Health & Family Welfare along with the Minister of Chemicals and Fertilizers. Employing this software allows for efficient collection and scrutiny of adverse events linked to medications and medical devices. Therefore, easing the reporting procedure for both consumers and medical professionals alike. This move has significantly bolstered India’s pharmacovigilance infrastructure assuring a wider collection of safety data and improving drug safety observation. The ADRMS has been designed to elevate the efficiency of drug safety regulation and adherence to standards, which reinforces India’s position as a major player in the international pharmaceutical arena.

View the full report here:

https://www.thebusinessresearchcompany.com/report/pharmacovigilance-global-market-report

What Are the Key Elements That Define the Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug’s advantages outweigh its hazards, and it doesn’t end once the drugs are approved.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5928

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model